JP2009543567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543567A5 JP2009543567A5 JP2009519869A JP2009519869A JP2009543567A5 JP 2009543567 A5 JP2009543567 A5 JP 2009543567A5 JP 2009519869 A JP2009519869 A JP 2009519869A JP 2009519869 A JP2009519869 A JP 2009519869A JP 2009543567 A5 JP2009543567 A5 JP 2009543567A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- stretch
- nucleotides
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002773 nucleotide Substances 0.000 claims 75
- 125000003729 nucleotide group Chemical group 0.000 claims 74
- 150000007523 nucleic acids Chemical class 0.000 claims 73
- 108020004707 nucleic acids Proteins 0.000 claims 68
- 102000039446 nucleic acids Human genes 0.000 claims 68
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims 26
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 26
- 239000005557 antagonist Substances 0.000 claims 12
- 239000000556 agonist Substances 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 238000009396 hybridization Methods 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 1
- 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 102000043525 human CXCL12 Human genes 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06014957.2 | 2006-07-18 | ||
| EP06014957 | 2006-07-18 | ||
| PCT/EP2007/006387 WO2008009437A2 (en) | 2006-07-18 | 2007-07-18 | Sdf-i binding nucleic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009543567A JP2009543567A (ja) | 2009-12-10 |
| JP2009543567A5 true JP2009543567A5 (enExample) | 2010-09-02 |
| JP5380287B2 JP5380287B2 (ja) | 2014-01-08 |
Family
ID=38947372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009519869A Active JP5380287B2 (ja) | 2006-07-18 | 2007-07-18 | Ｓｄｆ−１結合核酸 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US8314223B2 (enExample) |
| EP (1) | EP2041282B1 (enExample) |
| JP (1) | JP5380287B2 (enExample) |
| KR (2) | KR101466931B1 (enExample) |
| CN (2) | CN103555725B (enExample) |
| AR (1) | AR061929A1 (enExample) |
| AU (1) | AU2007276435C1 (enExample) |
| BR (1) | BRPI0714844B8 (enExample) |
| CA (1) | CA2658267C (enExample) |
| DK (1) | DK2041282T3 (enExample) |
| ES (1) | ES2663404T3 (enExample) |
| MX (1) | MX2009000656A (enExample) |
| PL (1) | PL2041282T3 (enExample) |
| PT (1) | PT2041282T (enExample) |
| RU (1) | RU2590709C2 (enExample) |
| WO (1) | WO2008009437A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008009437A2 (en) | 2006-07-18 | 2008-01-24 | Noxxon Pharma Ag | Sdf-i binding nucleic acids |
| KR101589442B1 (ko) * | 2007-08-06 | 2016-02-01 | 녹손 파르마 아게 | 에스디에프-1 결합형 핵산 및 이의 용도 |
| JP5463621B2 (ja) * | 2008-02-27 | 2014-04-09 | ソニー株式会社 | 標的物質の定量方法 |
| US8710021B2 (en) * | 2008-06-11 | 2014-04-29 | Bionucleon S.R.L. | Inhibition of HRP-3 using modified oligonucleotides |
| TWI578992B (zh) * | 2009-04-30 | 2017-04-21 | 諾克森製藥股份有限公司 | 與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類 |
| WO2012025251A1 (en) * | 2010-08-27 | 2012-03-01 | Noxxon Pharma Ag | Nucleic acids for treatment of chronic complications of diabetes |
| AU2011300818B2 (en) * | 2010-09-09 | 2015-11-12 | TME Pharma AG | SDF-1 binding nucleic acids and the use thereof in cancer treatment |
| EP2633053A1 (en) * | 2010-10-29 | 2013-09-04 | Noxxon Pharma AG | Use of hepcidin binding nucleic acids for depletion of hepcidin from the body |
| CN104661664B (zh) | 2012-07-13 | 2020-07-03 | 波涛生命科学有限公司 | 手性控制 |
| WO2016096640A2 (en) * | 2014-12-17 | 2016-06-23 | Cancer Research Technology Ltd | Anti-cxcl12 antibody molecules and their uses |
| US11371045B2 (en) * | 2016-04-15 | 2022-06-28 | Noxxon Pharma Ag | Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors |
| US11221270B2 (en) * | 2018-02-27 | 2022-01-11 | Kevan M Evans | Method and apparatus for detecting slow leaks |
| WO2021178923A1 (en) | 2020-03-06 | 2021-09-10 | Drinksavvy, Inc. | Devices and methods for detecting a target analyte of interest |
| CN115997122A (zh) | 2020-06-26 | 2023-04-21 | 拉夸里亚创药株式会社 | 类维生素a与癌治疗剂的组合疗法有效的癌患者的选择方法、及类维生素a与癌治疗剂的组合药物 |
| WO2023154452A1 (en) | 2022-02-11 | 2023-08-17 | Waypoint Bio, Inc. | Cellular staining probes for analyte detection |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US5840867A (en) | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
| IE920562A1 (en) * | 1991-02-21 | 1992-08-26 | Gilead Sciences | Aptamer specific for biomolecules and method of making |
| US5582981A (en) | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
| EP1072273B1 (en) * | 1998-03-24 | 2006-07-26 | Chugai Seiyaku Kabushiki Kaisha | Vascularization inhibitors |
| US6670149B1 (en) * | 1999-03-01 | 2003-12-30 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel nucleic acids and uses therefor |
| US6949243B1 (en) | 1999-11-24 | 2005-09-27 | Schering Corporation | Methods of inhibiting metastasis |
| EP1133988A1 (en) | 2000-03-11 | 2001-09-19 | Biognostik Gesellschaft für biomolekulare Diagnostik mbH | Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| EP1717583A3 (en) * | 2001-06-07 | 2007-10-10 | ChemoCentryx Inc | Cell migration assay |
| US7468253B2 (en) | 2001-06-07 | 2008-12-23 | Chemocentryx, Inc. | Method for multiple chemokine receptor screening for antagonists using RAM assay |
| GB0225833D0 (en) | 2002-11-06 | 2002-12-11 | Univ Leeds | Nucleic acid ligands and uses therefor |
| ES2729826T3 (es) | 2004-09-23 | 2019-11-06 | Arc Medical Devices Inc | Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato |
| DE502005009920D1 (de) * | 2004-11-29 | 2010-08-26 | Noxxon Pharma Ag | Vasopressin bindende l-nukleinsäure |
| BRPI0707446A2 (pt) | 2006-02-02 | 2011-05-03 | Allergan Inc | composições e métodos para o tratamento de doença oftálmica |
| WO2008009437A2 (en) | 2006-07-18 | 2008-01-24 | Noxxon Pharma Ag | Sdf-i binding nucleic acids |
| SG178712A1 (en) | 2006-10-02 | 2012-03-29 | Medarex Inc | Human antibodies that bind cxcr4 and uses thereof |
| JP5296701B2 (ja) | 2006-11-30 | 2013-09-25 | ユニバーシティ オブ バージニア パテント ファウンデーション | 線維性疾患および線維増殖性疾患を処置および診断するための方法 |
| KR101589442B1 (ko) | 2007-08-06 | 2016-02-01 | 녹손 파르마 아게 | 에스디에프-1 결합형 핵산 및 이의 용도 |
| US20090274687A1 (en) | 2008-05-02 | 2009-11-05 | University Of Miami | Attenuation of hypoxia induced cardiovascular disorders |
-
2007
- 2007-07-18 WO PCT/EP2007/006387 patent/WO2008009437A2/en not_active Ceased
- 2007-07-18 PL PL07786160T patent/PL2041282T3/pl unknown
- 2007-07-18 EP EP07786160.7A patent/EP2041282B1/en active Active
- 2007-07-18 PT PT77861607T patent/PT2041282T/pt unknown
- 2007-07-18 DK DK07786160.7T patent/DK2041282T3/en active
- 2007-07-18 MX MX2009000656A patent/MX2009000656A/es active IP Right Grant
- 2007-07-18 CA CA2658267A patent/CA2658267C/en active Active
- 2007-07-18 AR ARP070103212A patent/AR061929A1/es active IP Right Grant
- 2007-07-18 AU AU2007276435A patent/AU2007276435C1/en active Active
- 2007-07-18 RU RU2009105494/10A patent/RU2590709C2/ru active
- 2007-07-18 ES ES07786160.7T patent/ES2663404T3/es active Active
- 2007-07-18 JP JP2009519869A patent/JP5380287B2/ja active Active
- 2007-07-18 BR BRPI0714844A patent/BRPI0714844B8/pt active IP Right Grant
- 2007-07-18 CN CN201310486348.1A patent/CN103555725B/zh active Active
- 2007-07-18 CN CN2007800305243A patent/CN101506364B/zh active Active
- 2007-07-18 KR KR1020097000923A patent/KR101466931B1/ko active Active
- 2007-07-18 KR KR1020137020754A patent/KR101561652B1/ko active Active
-
2009
- 2009-01-18 US US12/374,311 patent/US8314223B2/en active Active
-
2012
- 2012-10-13 US US13/651,385 patent/US9035038B2/en active Active
-
2015
- 2015-05-06 US US14/705,809 patent/US9822369B2/en active Active
-
2017
- 2017-11-20 US US15/818,618 patent/US20180163207A1/en not_active Abandoned
-
2020
- 2020-11-09 US US17/092,390 patent/US20210139909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543567A5 (enExample) | ||
| Wain et al. | Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank | |
| Janicki et al. | Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting | |
| RU2009105494A (ru) | Sdf-1-связывающие нуклеиновые кислоты | |
| US9206429B2 (en) | Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions | |
| JP2012525124A5 (enExample) | ||
| JP2013524792A5 (enExample) | ||
| Petersen et al. | Association of beta‐adrenergic receptor polymorphisms and mortality in carvedilol‐treated chronic heart‐failure patients | |
| EA020795B1 (ru) | Генетические маркеры, ассоциированные с ответом на интерферон-альфа | |
| Liu et al. | Designed compounds for recognition of 10 base pairs of DNA with two at binding sites | |
| Desai et al. | Efficacy of cochleated amphotericin B in mouse and human mucocutaneous candidiasis | |
| RU2008136907A (ru) | Нуклеиновые кислоты, связывающиеся с мср-1 | |
| Tang et al. | Role of gene polymorphisms/haplotypes and serum levels of interleukin-17A in susceptibility to viral myocarditis | |
| Choi et al. | Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting | |
| JP2014533098A5 (enExample) | ||
| Reay et al. | CYP2B6 haplotype predicts efavirenz plasma concentration in black South African HIV-1-infected children: a longitudinal pediatric pharmacogenomic study | |
| Zheng et al. | An update on genome-wide association studies of hypertension | |
| EP3827082B1 (en) | Icam-1 aptamers, diagnostic and therapeutic uses thereof | |
| JP2008501632A5 (enExample) | ||
| Twigg et al. | Measurement of antiretroviral drugs in the lungs of HIV-infected patients | |
| WO2021262911A1 (en) | Aptamers for personal health care applications | |
| Calderon-Ospina et al. | A pharmacogenomic dissection of a rosuvastatin-induced rhabdomyolysis case evokes the polygenic nature of adverse drug reactions | |
| US10155995B2 (en) | Mutations in PDGFRB and NOTCH3 as causes of autosomal dominant infantile myofibromatosis | |
| Hu et al. | Effect of food and polymorphisms in SLCO2B1, CYP3A4 and UGT1A4 on pharmacokinetics of abiraterone and its metabolites in Chinese volunteers | |
| JP7018544B2 (ja) | 心房細動の処置のためのブシンドロールを伴う方法および組成物 |